Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Watch our video to learn more about AccuRhythm AI algorithms, now enhanced to further improve accuracy without compromising sensitivity.
Atrial fibrillation (AF) and Pause AccuRhythm AI algorithms further enhance the accuracy of the LINQ II ICM data.1–3 The cloud-based artificial intelligence system reduces false alerts while retaining true alerts, so you can maintain diagnostic yield and spend more time on the human side of care.
AccuRhythm AI algorithms are a groundbreaking platform that can seamlessly and remotely apply deep learning algorithms to already-transmitting LINQ II devices. They were rigorously trained and were developed based on over one million professionally adjudicated ECGs for smarter, more accurate insight without data bias.1
AccuRhythm AI algorithms further address the two most common sources of these ICM false alerts — AF and Pause.1,2,4
Validation data from real-world LINQ II ICM patients demonstrated:
in false Pause alerts.
in false AF alerts.
Preserved true alerts1:
true AF alerts preserved
true Pause alerts preserved
Reduce false alerts1,2
Leveraging more than 25 years of ICM expertise and a robust history of in-human ICM data, Medtronic is uniquely equipped to build deep-learning AI algorithms that evaluate the entire waveform in ICM ECGs.1
91% reduction in LINQ II ICM false alerts1
Check out how this impacts your clinic's time. The AccuRhythm AI algorithms can save clinicians approximately 401 hours of false alert review yearly for every 200 LINQ II ICM patients.*1
* The validation study performance and time study results were projected onto 16,301 LINQ II patients to calculate the time saved per year in 200 LINQ II ICM patients.
The development of the AccuRhythm AI platform to transform ICM data to deliver clinically meaningful and actionable alerts upheld the Medtronic AI Compass, a beacon of guiding principles on the ethical use of artificial intelligence in healthcare technology. The AI Compass represents the principles we use to guide our journey and the commitments we make to the users of our technologies, including patients and healthcare providers.
As we continue to innovate and deliver on our pipeline of AI powered enhancements to our LINQ family of ICMs, we commit to ensure that patient care, safety, effectiveness, quality, and accountability drive our innovation. This latest AF algorithm enhancement is no exception, ensuring preservation of true alerts.
Learn more about the LINQ II ICM, which is compatible with AccuRhythm AI algorithms.
Get the latest updates and information on the LINQ family of ICMs, including educational resources, upcoming events, published clinical data, and more.
Implanting LINQ ICMs is faster and easier than you may think. Learn more by requesting a demo by a Medtronic representative.
Radtke A, Hall M. AccuRhythm AI AF & Pause Algorithms White Paper. April 2023. Medtronic data on file.
Cheng YJ, Ousdigian KT, Koehler J, Cho YK, Kloosterman M. Innovative Artificial Intelligence Application Reduces False Pause Alerts while Maintaining Perfect True Pause Sensitivity for Insertable Cardiac Monitors. Presented at HRS 2021.
AccuRhythm AI Clinician Manual Supplements M015316C001 and M048573C001.
Radtke A, Ousdigian KT, Haddad TD, Koehler JL, Colombowala IK. Artificial Intelligence Enables Dramatic Reduction of False Atrial Fibrillation Alerts from Insertable Cardiac Monitors. Presented at HRS 2021.